President Trump’s move to potentially impose tariffs on imported drugs is a risky political decision, as it could lead to higher prices and shortages of essential medications for Americans.
The Trump administration released a Federal notice on Monday, stating that an investigation had been initiated to assess the impact of drug imports on US national security.
Despite Trump’s intentions to implement such tariffs to bring back manufacturing to the US, experts doubt tariffs will achieve this goal given the high costs and time involved in shifting production. It remains unclear when these planned tariffs may take effect.
The investigation launched by Trump falls under legal authority known as Section 232, similar to inquiries made in other industries such as automobiles and lumber.
Source: www.nytimes.com